Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
NCT02245217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2021-10-15
Summary
Study of multi-tracer PET scans to assess response to gemcitabine in pancreatic cancer
Conditions
Interventions
- DEVICE
-
PET/CT scan to assess treatment efficacy
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-12
- Primary Completion
- 2016-03-17
- Completion
- 2016-03-17
Countries
- United States
Study Locations
More Related Trials
-
The Predictive Value of CT-PET in Esophageal Cancer
NCT02385604 ·Status: COMPLETED
-
Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
NCT00885248 ·Status: UNKNOWN
-
Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.
NCT03202199 ·Status: UNKNOWN ·Phase: NA
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Dual-Tracer Theranostic PET
NCT05680675 ·Status: COMPLETED ·Phase: NA
-
11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE
NCT02519075 ·Status: COMPLETED
-
Nonfunctional Pancreatic NET and PET Imaging
NCT02621541 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
NCT04161781 ·Status: COMPLETED
-
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response
NCT04588025 ·Status: RECRUITING ·Phase: NA
-
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
NCT05957250 ·Status: RECRUITING ·Phase: NA
-
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
NCT00351728 ·Status: COMPLETED
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer
NCT06203613 ·Status: RECRUITING ·Phase: NA
-
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00227539 ·Status: COMPLETED ·Phase: PHASE2
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
NCT01712815 ·Status: TERMINATED ·Phase: NA
-
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
NCT03077334 ·Status: COMPLETED
-
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)
NCT01050283 ·Status: TERMINATED ·Phase: PHASE1
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
NCT04831541 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients
NCT00585117 ·Status: TERMINATED ·Phase: NA
-
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
NCT06173310 ·Status: RECRUITING ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00388024 ·Status: COMPLETED
-
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
NCT04804371 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA